Goldman, Everstone seek $1.7B valuation for sale of Omega Healthcare

Goldman Sachs Asset Management and Everstone Capital are considering divesting a controlling stake in Omega Healthcare for about $1.7bn.

According to the sources, the stake sale process is currently in early stages.

One of the sources said: “Goldman, which holds a majority stake in the company, is thinking of not selling its entire stake in Omega and will probably end up keeping a 20% stake, while Everstone will sell its entire stake.”

Omega Healthcare specialises in business process services and revenue cycle management, as well as provides other support functions for healthcare entities.

The company’s services are designed to streamline medical billing, coding, and collection processes.

It also offers virtual nursing services, which cover care continuation, triage, improvement of clinical documentation, and re-admittance avoidance.

Omega Healthcare combines the advanced medical coding staff with analytics, technology, and automation capabilities to deliver a comprehensive range of outsourced solutions tailored for the healthcare sector.

In 2022, the company expanded its portfolio by acquiring ApexonHealth, which focuses on AI and automation-based revenue cycle management, along with payor solutions.

Additionally, the company acquired Vasta Global, a company that specialises in real-world data abstraction and analytics for the oncology market.

In October 2023, Omega Healthcare launched the Omega Digital Platform (ODP) to help reduce administrative burdens for healthcare organisations.

The ODP is designed to leverage advanced proprietary technologies to streamline workflows and improve financial performance. GlobalData